Partial mandibulectomy in patient with osteopetrosis.
DOI:
https://doi.org/10.35954/SM2025.44.1.6.e501Keywords:
Bone Density, Osteoclasts, Osteomyelitis, Osteopetrosis, Mandibular Osteotomy, Bone Resorption, Bone Remodeling.Abstract
Introduction: Osteopetrosis is a rare disorder characterized by abnormal osteoclast function characterized by increased bone density.
These patients have increased susceptibility to infection, facial deformity, delayed tooth eruption and pathological fractures.
Case report: We present an adult patient with submental skin fistulas due to mandibular osteomyelitis as a starting point of dental infections.
Materials and methods: Under general anesthesia and nasotracheal intubation a submandibular and submental approach was performed. The affected mandibular portion was cut with a surgical saw and the mandibular contour was reconstructed with a 2.7 plate.
Results: The patient evolved favorably without complications.
NOTE: This article was approved by the Editorial Committee.
Received for review: September 2024.
Accepted for publication: December 2024.
Correspondence: 8 de octubre 3020, C.P. 11100. Montevideo, Uruguay. Tel: (+598) 24876666 / 1357 / 1679.
Contact e-mail: sebastian.larranaga@gmail.com
Downloads
Metrics
References
(1) Neville BW, Damn DD, Allen CM, Bouquot JE. Oral and Maxillofacial pathology. Philadelphia : W. B. Saunders, 2002. pp.125-140.
(2) Steiner M, Gould AR, Means WR. Osteomyelitis of the mandible associated with os-teopetrosis. J Oral Maxillofac Surg 1983 Jun; 41(6):395-405. DOI: 10.1016/s0278-2391(83)80011-1. PMID: 6574222. DOI: https://doi.org/10.1016/S0278-2391(83)80011-1
(3) Wu CC, Econs MJ, DiMeglio LA, Insogna KL, Levine MA, Orchard PJ, et al. Diag-nosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group. J Clin Endocrinol Metab 2017 Sep 1; 102(9):3111-3123. DOI: 10.1210/jc.2017-01127. PMID: 28655174. DOI: https://doi.org/10.1210/jc.2017-01127
(4) Vudiniabola S, Pirone C, Williamson J, Goss AN. Hyperbaric oxygen in the therapeu-tic management of osteoradionecrosis of the facial bones. Int J Oral Maxillofac Surg 2000 Dec; 29(6):435-8. PMID: 11202324. DOI: https://doi.org/10.1034/j.1399-0020.2000.290608.x
(5) Riu LM, Ortas Xavier, Quirós M, Rodríguez Romero C, Raya A. Tratamiento farma-cológico de la osteomielitis. El Peu 2009; 29(1):30-38.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 : Sebastian Larrañaga, Marco Zanotta y Silvia Isasmendi.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
